Bellevue Group Ag Pfizer Inc Transaction History

Bellevue Group Ag

$4.39 Billion
Q2 2025

A detailed history of Bellevue Group Ag transactions in Pfizer Inc stock. As of the latest transaction made, Bellevue Group Ag holds 70,915 shares of PFE stock, worth $1.75 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

70,915

Previous 120,746 41.27%

Holding current value

$1.75 Million

Previous $3.06 Million 43.84%

% of portfolio

0.04%

Previous 0.07%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$21.59 - $24.84 $1.08 Million - $1.24 Million	-49,831 Reduced 41.27%	70,915 $1.72 Million
Q1 2025 May 14, 2025	SELL	$25.01 - $27.13 $520,558 - $564,683	-20,814 Reduced 14.7%	120,746 $3.06 Million
Q4 2024 Feb 14, 2025	BUY	$24.8 - $30.19 $12,028 - $14,642	485 Added 0.34%	141,560 $3.76 Million
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $1.45 Million - $1.65 Million	52,461 Added 59.2%	141,075 $4.08 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $1.38 Million - $1.62 Million	54,780 Added 161.91%	88,614 $2.48 Million
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $283,909 - $326,019	10,966 Added 47.95%	33,834 $938,000
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $347,868 - $451,843	13,313 Added 139.33%	22,868 $658,000
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $306,619 - $358,408	9,555 New	9,555 $316,000
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $1.89 Million - $2.46 Million	-47,978 Reduced 6.08%	740,695 $30.2 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $892,322 - $1.16 Million	21,373 Added 2.79%	788,673 $40.4 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $2.99 Million - $3.65 Million	-68,384 Reduced 8.18%	767,300 $33.6 Million
Q2 2022 Aug 11, 2022	BUY	$46.53 - $55.17 $36.7 Million - $43.5 Million	789,184 Added 1697.17%	835,684 $43.8 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $3.04 Million - $3.77 Million	-66,500 Reduced 58.85%	46,500 $2.41 Million
Q4 2021 Feb 10, 2022	BUY	$41.32 - $61.25 $553,688 - $820,750	13,400 Added 13.45%	113,000 $6.67 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $3.91 Million - $5.02 Million	99,600 New	99,600 $4.28 Million
Q1 2021 May 12, 2021	SELL	$33.49 - $37.77 $2.47 Million - $2.79 Million	-73,900 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $2.35 Million - $2.75 Million	73,900 New	73,900 $2.71 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $2.71 Million - $3.29 Million	-90,000 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$27.03 - $38.62 $810,900 - $1.16 Million	30,000 Added 50.0%	90,000 $2.94 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $658,400 - $747,200	20,000 Added 50.0%	60,000 $2.35 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $1.5 Million - $1.65 Million	40,000 New	40,000 $1.7 Million
Q4 2018 Feb 12, 2019	SELL	$38.47 - $43.86 $1.12 Million - $1.28 Million	-29,200 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	29,200	29,200 $981,000

Others Institutions Holding PFE

# of Institutions

3,314

Shares Held

3.65B

Call Options Held

96.6M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $138B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account

Bellevue Group Ag Pfizer Inc Transaction History